Last $1.08 USD
Change Today -0.0301 / -2.71%
Volume 199.9K
DARA On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 10:59 AM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

dara biosciences inc (DARA) Snapshot

Open
$1.09
Previous Close
$1.11
Day High
$1.12
Day Low
$1.07
52 Week High
01/22/14 - $4.40
52 Week Low
05/19/14 - $1.02
Market Cap
21.1M
Average Volume 10 Days
341.0K
EPS TTM
$-1.51
Shares Outstanding
19.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for DARA BIOSCIENCES INC (DARA)

Related News

No related news articles were found.

dara biosciences inc (DARA) Related Businessweek News

No Related Businessweek News Found

dara biosciences inc (DARA) Details

DARA BioSciences, Inc., a development stage biopharmaceutical company, develops and commercializes oncology treatment and supportive care pharmaceutical products in the United States. It offers Soltamox for the chronic treatment of breast cancer or for cancer prevention in certain susceptible breast cancer subgroups. The company’s oncology supportive care pharmaceutical products comprise Gelclair, an oral gel for the treatment of oral mucositis; and Bionect for the management of irritation of the skin, as well as first and second degree burns. Its clinical development programs include KRN5500, a novel, non-narcotic/non-opioid intravenous product for the treatment of cancer patients with painful chronic chemotherapy induced peripheral neuropathy, which has completed Phase 2a development; and DB959, a drug candidate for the treatment of type 2 diabetes and dyslipidemia. DARA BioSciences, Inc. was incorporated in 2002 and is headquartered in Raleigh, North Carolina.

13 Employees
Last Reported Date: 02/4/14
Founded in 2002

dara biosciences inc (DARA) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $275.0K
Executive Chairman and Chief Medical Officer
Total Annual Compensation: $325.0K
Chief Financial Officer, Chief Accounting Off...
Total Annual Compensation: $200.0K
Compensation as of Fiscal Year 2013.

dara biosciences inc (DARA) Key Developments

DARA BioSciences, Inc Presents at Aegis Capital 2014 Healthcare & Technology Conference, Sep-12-2014 10:00 AM

DARA BioSciences, Inc Presents at Aegis Capital 2014 Healthcare & Technology Conference, Sep-12-2014 10:00 AM. Venue: The Encore at Wynn Las Vegas, 3121 Las Vegas Blvd. South, Las Vegas, NV 89109, United States. Speakers: David J. Drutz, Executive Chairman and Chief Medical Officer.

DARA BioSciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2014

DARA BioSciences Inc. reported earnings results for the second quarter and six months ended June 30, 2014. For the quarter, net product Revenue was $409.4 million compared to $76.9 million a year ago. Net loss attributed to controlling interest was $2,583.1 million compared to $2,554.2 million a year ago. For the six months, net product Revenue was $570.9 million compared to $98.1 million a year ago. Net loss attributed to controlling interest was $5,241.1 million compared to $5,076.8 million a year ago.

DARA BioSciences, Inc to Report Q2, 2014 Results on Aug 12, 2014

DARA BioSciences, Inc announced that they will report Q2, 2014 results After-Market on Aug 12, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DARA:US $1.08 USD -0.0301

DARA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Access Pharmaceuticals Inc $0.25 USD -0.01
View Industry Companies
 

Industry Analysis

DARA

Industry Average

Valuation DARA Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DARA BIOSCIENCES INC, please visit www.darabiosciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.